These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 10188718

  • 1. Selection of carbohydrate antigens in human epithelial ovarian cancers as targets for immunotherapy: serous and mucinous tumors exhibit distinctive patterns of expression.
    Federici MF, Kudryashov V, Saigo PE, Finstad CL, Lloyd KO.
    Int J Cancer; 1999 Apr 12; 81(2):193-8. PubMed ID: 10188718
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory role of prohibitin in human ovarian epithelial cancer.
    Jia L, Ren JM, Wang YY, Zheng Y, Zhang H, Zhang Q, Kong BH, Zheng WX.
    Int J Clin Exp Pathol; 2014 Apr 12; 7(5):2247-55. PubMed ID: 24966933
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors.
    Tashiro Y, Yonezawa S, Kim YS, Sato E.
    Hum Pathol; 1994 Apr 12; 25(4):364-72. PubMed ID: 8163269
    [Abstract] [Full Text] [Related]

  • 4. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
    Davidson B, Gotlieb WH, Ben-Baruch G, Kopolovic J, Goldberg I, Nesland JM, Berner A, Bjåmer A, Bryne M.
    Gynecol Oncol; 2000 Apr 12; 77(1):35-43. PubMed ID: 10739688
    [Abstract] [Full Text] [Related]

  • 5. [Expression of folate receptor alpha in ovarian epithelial tumors].
    Shen DH, Xie JL, Zhang YL, Wang Y.
    Zhonghua Bing Li Xue Za Zhi; 2010 Nov 12; 39(11):747-51. PubMed ID: 21215165
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Five years survival in patients with endometrioid ovarian cancer versus patients with serous ovarian cancer].
    Ivanov S, Batashki I.
    Akush Ginekol (Sofiia); 2008 Nov 12; 47(5):9-11. PubMed ID: 19227770
    [Abstract] [Full Text] [Related]

  • 12. Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types.
    Kabawat SE, Bast RC, Welch WR, Knapp RC, Colvin RB.
    Am J Clin Pathol; 1983 Jan 12; 79(1):98-104. PubMed ID: 6336888
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
    Sakakibara K, Ueda R, Ohta M, Nakashima N, Tomoda Y, Takahashi T.
    Cancer Res; 1988 Aug 15; 48(16):4639-45. PubMed ID: 2456145
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ovarian yolk sac tumor associated with endometrioid carcinoma and mucinous cystadenoma of the ovary.
    Lopez JM, Malpica A, Deavers MT, Ayala AG.
    Ann Diagn Pathol; 2003 Oct 15; 7(5):300-5. PubMed ID: 14571433
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.